2021/10/14
-
*Safety of ustekinumab or vedolizumab in inflammatory bowel disease
17:00-17:30
Guangdong Hall I
Biologics Forum: Interaction with ECCO experts
Speaker
2021/10/15
-
16:00-18:00
Zhuhai Hall I
Challenge Cases
Chair